Singapore markets closed

Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
8.22-0.31 (-3.63%)
At close: 03:04PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,152,197
1,209,199
1,242,603
1,053,505
777,296
Cost of revenue
475,829
466,915
480,498
455,721
358,408
Gross profit
676,367
742,284
762,105
597,783
418,888
Operating expenses
Research development
40,927
50,011
39,185
37,451
27,839
Selling general and administrative
313,397
302,009
304,571
301,310
260,142
Total operating expenses
498,956
494,400
469,381
467,932
412,975
Operating income or loss
177,412
247,884
292,724
129,851
5,914
Interest expense
688.3799
671.7476
460.3791
15.4741
170.2589
Income before tax
107,753
177,017
290,539
93,537
-665,093
Income tax expense
39,995
56,306
77,493
27,434
19,382
Income from continuing operations
67,757
120,712
213,046
66,104
-684,475
Net income
72,555
126,200
218,787
66,481
-687,660
Net income available to common shareholders
72,555
126,200
218,787
66,481
-687,660
Basic EPS
0.62
0.31
0.54
0.17
-1.71
Diluted EPS
0.62
0.31
0.54
0.17
-1.71
Basic average shares
405,306
407,096
405,161
391,063
402,140
Diluted average shares
405,306
407,096
405,161
391,063
402,140